Asia

India Expands Under-Four Warning to All Chlorpheniramine–Phenylephrine Drug Combinations

Read this story on The State of Israel

Published

Courtroom-sketch editorial illustration of an Indian pharmacist separating unlabelled cough-medicine bottles while explaining child-safety guidance to a mother holding a toddler, rendered in warm ochre and slate-blue pastel strokes.

India's Health Ministry has required every fixed-dose formulation containing chlorpheniramine maleate and phenylephrine hydrochloride to warn that it must not be used in children younger than four. The warning must appear on labels, package inserts and promotional literature. The notification, published in the Gazette on August 21, followed the Drugs Technical Advisory Board's February 16 recommendation.

Sources

Primary sources:1

Related stories

  1. FDA Approves Mounjaro to Cut Cardiovascular Risk in High-Risk Adults With Type 2 Diabetes
  2. Gauteng Health Opens Probe Into Alleged Bribery and Queue-Jumping
  3. Australia Confirms Its First H5 Bird Flu Case in a Mammal, a Fur Seal in South Australia
  4. 112 Rwandan Police Officers Donate Blood for Patients
  5. Auckland Children’s Dental-Surgery Waitlist Falls by Two-Thirds

Something went wrong

We couldn't complete that action. Check your connection and try again.